“Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s51. doi:10.25251/skin.5.supp.51.